DYAI
Dyadic International Inc., DE

1,884
Loading...
Loading...
News
all
press releases
Dyadic International Full Year 2023 Earnings: Misses Expectations
Dyadic International ( NASDAQ:DYAI ) Full Year 2023 Results Key Financial Results Revenue: US$2.90m (down 1.1% from FY...
Simply Wall St·1y ago
News Placeholder
More News
News Placeholder
Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript
Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript...
SeekingAlpha·1y ago
News Placeholder
Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript
Dyadic International, Inc. (DYAI) Q4 2023 Earnings Call Transcript...
Seeking Alpha: Transcripts·1y ago
News Placeholder
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the fourth...
InvestorPlace·1y ago
News Placeholder
Recap: Dyadic International Q4 Earnings
read more...
Benzinga·1y ago
News Placeholder
Dyadic International Announces Key Leadership Changes
Dyadic International (DYAI) has provided an update. On March 26, 2024, the board of directors of a prominent company announced significant leadersh...
TipRanks Financial Blog·1y ago
News Placeholder
Dyadic Reports 2023 Full Year Results and Recent Company Progress
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...
Globe Newswire·1y ago
News Placeholder
Dyadic Announces Change in Board and Management Leadership Roles
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ( Dyadic , we , us , our , or the Company ) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Globe Newswire·1y ago
News Placeholder
Head-To-Head Contrast: Dyadic International (NASDAQ:DYAI) & Enzon Pharmaceuticals (OTCMKTS:ENZN)
Enzon Pharmaceuticals (OTCMKTS:ENZN Get Free Report) and Dyadic International (NASDAQ:DYAI Get Free Report) are both medical companies, but which is the better stock? We will contrast...
Zolmax·1y ago
News Placeholder
Dyadic to Attend Industry Events in April
JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ( Dyadic , or the Company ) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Globe Newswire·1y ago

Latest DYAI News

View

Advertisement. Remove ads.

Advertisement. Remove ads.